Allogene Therapeutics, Inc.
ALLO
22 insider filings · Latest: Aug 21, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 4 7:15 PM | Humer Franz B | Proposed Sale | 9,221 | $2.30 | $21.2K | — | View → |
| Dec 3, 2024 | Dec 2 7:11 PM | Humer Franz B | Proposed Sale | 9,221 | $2.48 | $22.9K | — | View → |
| Oct 21, 2024 | Oct 21 8:05 PM | Parker Geoffrey M. | Proposed Sale | 36,404 | $2.84 | $103.5K | — | View → |
| Aug 21, 2024 | Aug 21 8:18 PM | Douglas Earl Martin | Proposed Sale | 28,310 | $2.79 | $78.8K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 6 9:51 PM | Zachary RobertsPresident and CEO | Grant/Award | 610,720 | $2.11 | 476,190(D) | View → |
| Jun 18, 2026 | Jun 23 8:35 PM | Joshua A KazamDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:35 PM | Joshua A KazamDirector | Option Exercise | 47,700 | — | 0(D) | View → |
| Jun 18, 2026 | Jun 23 8:34 PM | Deborah M. MessemerDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:33 PM | Stephen MayoDirector | Grant/Award | 144,400 | $2.00 | 144,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:32 PM | Vicki L SatoDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:29 PM | Owen N. WitteDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:28 PM | Franz B HumerDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Jun 18, 2026 | Jun 23 8:26 PM | Elizabeth A. BarrettDirector | Grant/Award | 95,400 | — | 95,400(D) | View → |
| Feb 2, 2026 | Feb 4 10:20 PM | Benjamin Machinas BeneskiSVP, Chief Technical Officer | Grant/Award | 479,477 | $1.87 | 105,720(D) | View → |
| Feb 2, 2026 | Feb 4 10:18 PM | Chang David DDirector, President and CEO | Grant/Award | 1,780,517 | $1.87 | 392,586(D) | View → |
| Feb 2, 2026 | Feb 4 10:16 PM | Geoffrey M. ParkerCHIEF FINANCIAL OFFICER | Grant/Award | 691,552 | $1.87 | 152,480(D) | View → |
| Feb 2, 2026 | Feb 4 10:12 PM | Earl Martin DouglasSVP, General Counsel | Grant/Award | 691,552 | $1.87 | 152,480(D) | View → |
| Feb 2, 2026 | Feb 4 10:09 PM | Annie YoshiyamaSVP, Finance | Grant/Award | 230,518 | $1.87 | 50,827(D) | View → |
| Feb 2, 2026 | Feb 4 10:07 PM | Zachary RobertsEVP of R&D | Grant/Award | 922,070 | $1.87 | 203,307(D) | View → |
| Feb 2, 2026 | Feb 4 10:04 PM | Arie BelldegrunDirector | Grant/Award | 1,192,946 | $1.87 | 263,033(D) | View → |